Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

89Zr-bevacizumab PET

  • You have access
    Everolimus Reduces 89Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
    Sophie J. van Asselt, Sjoukje F. Oosting, Adrienne H. Brouwers, Alfons H.H. Bongaerts, Johan R. de Jong, Marjolijn N. Lub-de Hooge, Thijs H. Oude Munnink, Helle-Brit Fiebrich, Wim J. Sluiter, Thera P. Links, Annemiek M.E. Walenkamp and Elisabeth G.E. de Vries
    Journal of Nuclear Medicine July 1, 2014, 55 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.113.129056
  • You have access
    89Zr-Bevacizumab PET Imaging in Primary Breast Cancer
    Sietske B.M. Gaykema, Adrienne H. Brouwers, Marjolijn N. Lub-de Hooge, Rick G. Pleijhuis, Hetty Timmer-Bosscha, Linda Pot, Gooitzen M. van Dam, Sibylle B. van der Meulen, Johan R. de Jong, Joost Bart, Jakob de Vries, Liesbeth Jansen, Elisabeth G.E. de Vries and Carolien P. Schröder
    Journal of Nuclear Medicine July 1, 2013, 54 (7) 1014-1018; DOI: https://doi.org/10.2967/jnumed.112.117218
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire